Wells Fargo’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$10.4M 7603
2023
Q1
$10.4M Hold
100,000
﹤0.01% 1556
2022
Q4
$8.86M Buy
+100,000
New +$8.3M ﹤0.01% 1628
2021
Q4
Sell
-12,500
Closed -$1.64M 7274
2021
Q3
$1.64M Buy
+12,500
New +$1.64M ﹤0.01% 3843

Other funds holding CNMD

Wells Fargo's CNMD Position: Q1 2026 in Review

Wells Fargo reduced its CONMED (CNMD) stake by 44% in Q1 2026, selling an estimated $3.03M and leaving 96,369 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

Wells Fargo first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.6M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Wells Fargo held 96,369 shares of CONMED worth $3.41M as of Q1 2026.
  • Wells Fargo sold 74,449 CONMED shares in Q1 2026, an estimated $3.03M.
  • CONMED made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2884 holding.
  • Wells Fargo first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's CONMED position peaked at $85.6M in Q2 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.